-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on CVS Health, Raises Price Target to $95

Benzinga·12/10/2025 14:38:49
Listen to the news
Mizuho analyst Ann Hynes maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $88 to $95.